Table 4.
Summary of differences between neonatal and adult physiology that affect absorption/distribution of drugs (extracted from [13]).
Route of Administration | Impact on Absorption/Distribution | Reasons |
---|---|---|
Oral | Altered absorption | Neonatal pH is elevated in the stomach (increased for basic drugs and reduced for acidic drugs) Immature ontogeny of transporter expression |
Reduced absorption | Slower gastric emptying Reduced relative surface area in the intestine |
|
Increased absorption | Slower intestinal transit Reduced intestinal P-glycoprotein expression |
|
Rectal | Decreased surface area | Reduced relative surface area of rectum |
Respiratory | Decreased absorption | Immature lung branching and development Reduced lung capacity and inspiratory flow |
Nasal | No data shown | Potential for irritation in the nasal mucosa in neonates |
Dermal and transdermal | Increased absorption | Higher BSA/kg ratio Thinner stratum cornea layer More hydrated stratum corneum Higher relative surface area to bodyweight |
IV | Reduced distribution | Reduced blood volume |
Intramuscular | Reduced distribution | Reduced muscle mass |
Altered distribution | Variable muscle blood flow | |
Subcutaneous | Reduced distribution | Reduced subcutaneous fat |